DK1005652T3 - Bindingsassay under anvendelse af antigener indlejret i termoplast - Google Patents

Bindingsassay under anvendelse af antigener indlejret i termoplast

Info

Publication number
DK1005652T3
DK1005652T3 DK98940836T DK98940836T DK1005652T3 DK 1005652 T3 DK1005652 T3 DK 1005652T3 DK 98940836 T DK98940836 T DK 98940836T DK 98940836 T DK98940836 T DK 98940836T DK 1005652 T3 DK1005652 T3 DK 1005652T3
Authority
DK
Denmark
Prior art keywords
thermoplastics
binding assay
antigens
embedded
antigens embedded
Prior art date
Application number
DK98940836T
Other languages
English (en)
Inventor
John A Mcintyre
Original Assignee
Embedded Concepts Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Embedded Concepts Llc filed Critical Embedded Concepts Llc
Application granted granted Critical
Publication of DK1005652T3 publication Critical patent/DK1005652T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y10S530/817—Entrapped within the carrier, e.g. gel, hollow fibre
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK98940836T 1997-08-12 1998-08-12 Bindingsassay under anvendelse af antigener indlejret i termoplast DK1005652T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/909,889 US6177282B1 (en) 1997-08-12 1997-08-12 Antigens embedded in thermoplastic

Publications (1)

Publication Number Publication Date
DK1005652T3 true DK1005652T3 (da) 2006-10-30

Family

ID=25427986

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98940836T DK1005652T3 (da) 1997-08-12 1998-08-12 Bindingsassay under anvendelse af antigener indlejret i termoplast

Country Status (9)

Country Link
US (3) US6177282B1 (da)
EP (2) EP1005652B1 (da)
JP (1) JP2001512832A (da)
AU (1) AU753093B2 (da)
CA (1) CA2300381A1 (da)
DE (1) DE69835154T2 (da)
DK (1) DK1005652T3 (da)
ES (1) ES2268786T3 (da)
WO (1) WO1999008113A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177282B1 (en) * 1997-08-12 2001-01-23 Mcintyre John A. Antigens embedded in thermoplastic
US7018798B2 (en) * 1997-08-12 2006-03-28 Embedded Concepts, Llc Nucleic acid antigens embedded in thermoplastic
US6713309B1 (en) 1999-07-30 2004-03-30 Large Scale Proteomics Corporation Microarrays and their manufacture
US7407668B2 (en) * 2002-01-24 2008-08-05 Boston Scimed, Inc. Medical articles having enzymatic surfaces for localized therapy
EP1644473B1 (en) * 2003-06-03 2014-01-15 Cantimer Incorporated Phase change sensor
WO2005041662A1 (en) * 2003-10-03 2005-05-12 Visionary Biomedical, Inc. Method for treating collagenous tissue
US20050191644A1 (en) * 2003-10-06 2005-09-01 Research Organization of Information and Systems, President Methods for detecting biopolymers; biochips; methods for immobilizing antibodies; and substrates to which antibodies are immobilized
EP1680806A4 (en) * 2003-10-28 2008-07-30 Sachem Inc CLEANING SOLUTIONS AND MEDICAMENTS AND METHOD FOR THEIR USE
US7771999B2 (en) * 2004-04-28 2010-08-10 Vaxdesign Corp. Disease model incorporation into an artificial immune system (AIS)
US8071373B2 (en) 2004-04-28 2011-12-06 Sanofi Pasteur Vaxdesign Corp. Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS)
US7709256B2 (en) * 2004-04-28 2010-05-04 Vaxdesign Corp. Disease model incorporation into an artificial immune system (AIS)
US20070141552A1 (en) * 2004-04-28 2007-06-21 Warren William L Automatable artificial immune system (AIS)
US8298824B2 (en) 2004-04-28 2012-10-30 Sanofi Pasteur Vaxdesign Corporation Methods of evaluating a test agent in a diseased cell model
US7785883B2 (en) * 2004-04-28 2010-08-31 Vax Design Corp. Automatable artificial immune system (AIS)
US7785806B2 (en) * 2004-04-28 2010-08-31 Vaxdesign Corporation Method for determining the immunogenicity of an antigen
US7855074B2 (en) 2004-04-28 2010-12-21 Vaxdesign Corp. Artificial immune system: methods for making and use
US8030070B2 (en) * 2004-04-28 2011-10-04 Sanofi Pasteur Vaxdesign Corp. Artificial lymphoid tissue equivalent
US20060275270A1 (en) * 2004-04-28 2006-12-07 Warren William L In vitro mucosal tissue equivalent
EP1949108B1 (en) 2005-11-18 2013-09-25 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Modified cardiolipin and uses therefor
US8778619B2 (en) 2005-11-18 2014-07-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Oxidized cardiolipin and uses to detect cardiolipin antibodies
CA2634123C (en) 2005-12-21 2015-11-24 Vaxdesign Corporation In vitro germinal centers
EP1963491B1 (en) * 2005-12-21 2011-01-12 VaxDesign Corporation In vitro method of evaluating the potential reaction of an animal to an agent
US8642307B2 (en) * 2006-05-25 2014-02-04 Nalge Nunc International Corporation Cell culture surface chemistries
EP2043695B8 (en) * 2006-06-27 2012-02-29 Sanofi Pasteur VaxDesign Corporation Models for vaccine assessment
US8171270B2 (en) * 2006-12-29 2012-05-01 Intel Corporation Asynchronous control transfer
US8647837B2 (en) * 2007-07-16 2014-02-11 Sanofi Pasteur Vaxdesign Corp. Artificial tissue constructs comprising alveolar cells and methods for using the same
KR101679869B1 (ko) * 2008-04-05 2016-11-25 싱글 셀 테크놀로지, 아이엔씨. 생물학적 활성제의 생산을 위한 단일 세포의 스크리닝 방법
HUE054713T2 (hu) * 2013-06-18 2021-09-28 THERMOSOME GmbH Sztereospecifikus lipidek hosszantartó keringésû stimulus-érzékeny nanohordozó rendszerrel történõ lokoregionális terápiára
JP2015083969A (ja) * 2013-09-19 2015-04-30 株式会社リコー 検査装置、転写材、検査装置の製造方法、及び検査方法
US9757330B2 (en) 2013-10-18 2017-09-12 Industrial Technology Research Institute Recipe for in-situ gel, and implant, drug delivery system formed thereby
EP3694322B1 (en) 2017-10-09 2024-07-03 Terumo BCT Biotechnologies, LLC Lyophilization container and method of using same
US10191036B1 (en) 2018-03-22 2019-01-29 NUB4U, Inc. System for detecting and removing biological analytes in fluids
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
CN117288948B (zh) * 2023-06-19 2024-06-04 无锡嘉润诊断技术有限公司 抗凝血酶原抗体检测试剂盒

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4118349A (en) 1971-05-12 1978-10-03 Behringwerke Aktiengesellschaft Process for the manufacture of polystyrene latex compounds
US3766013A (en) * 1971-08-24 1973-10-16 American Cyanamid Co Preparation of water-insoluble carrier bound enzymes
US3767790A (en) * 1972-02-11 1973-10-23 Nat Patent Dev Corp Microorganisms
IT1008202B (it) * 1974-07-31 1976-11-10 Lostia Onofrio Fibre inglobanti anticorpi antige ni antisieri procedimento per la loro preparazione e loro impieghi
US4195127A (en) * 1975-06-10 1980-03-25 W. R. Grace & Co. Process for immobilizing proteins
US4360358A (en) 1980-03-07 1982-11-23 Yash Sharma Immunoassay with solid phase having coating containing blood platelet substitute
US4407957A (en) * 1981-03-13 1983-10-04 Damon Corporation Reversible microencapsulation of a core material
US4390343A (en) 1981-07-06 1983-06-28 Miles Laboratories, Inc. Multilayer analytical element having an impermeable radiation diffusing and blocking layer
US4459362A (en) 1982-02-02 1984-07-10 Hana Biologics, Inc. Immunoassay of phospholipid, such as phosphatidyl choline, in fluids such as amniotic
US4738724A (en) * 1983-11-04 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from starch compositions
US4609707A (en) * 1983-11-10 1986-09-02 Genetic Systems Corporation Synthesis of polymers containing integral antibodies
US4752638A (en) * 1983-11-10 1988-06-21 Genetic Systems Corporation Synthesis and use of polymers containing integral binding-pair members
US4673438A (en) * 1984-02-13 1987-06-16 Warner-Lambert Company Polymer composition for injection molding
IL72924A (en) * 1984-09-12 1988-07-31 I D L International Diagnostic Preparations for use in solid phase immunoassays comprising monoclonal antibodies covalently embedded in their immobilized hybridoma cells
US4656035A (en) * 1984-12-21 1987-04-07 University Of Tennessee Research Corporation Method of separating blood platelets
CA1272127A (en) * 1985-04-04 1990-07-31 Hybritech Incorporated Solid phase system for use in ligand-receptor assays
US5785989A (en) * 1985-05-01 1998-07-28 University Utah Research Foundation Compositions and methods of manufacturing of oral dissolvable medicaments
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US5200270A (en) * 1986-02-25 1993-04-06 Toyo Soda Manufacturing Co., Ltd. Carrier for a biologically active component for immunoassay or enzymatic reaction
DE3637421C1 (de) * 1986-11-03 1987-10-29 Nerbe Plus Ges Fuer Medizinisc Reaktionsgefaess fuer die Blutgerinnungsreaktion
US5723588A (en) * 1986-11-04 1998-03-03 Protein Polymer Technologies, Inc. Protein-enriched thermoplastics
US4822747A (en) * 1986-12-09 1989-04-18 Miles Inc. Polyacrylamide gel particles having hapten moieties bound thereto as immunoassay reagent
DE3887145T2 (de) * 1987-05-29 1994-04-28 North Sydney Area Health Serv Medizinische Testvorrichtung.
US4827944A (en) 1987-07-22 1989-05-09 Becton, Dickinson And Company Body fluid sample collection tube composite
US5236703A (en) * 1987-08-20 1993-08-17 Virex Inc. Polymeric substrates containing povidone-iodine as a control release biologically active agent
US5258503A (en) * 1987-09-08 1993-11-02 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Autoantibody adsorbent and apparatus for removing autoantibodies using the same
US5277915A (en) * 1987-10-30 1994-01-11 Fmc Corporation Gel-in-matrix containing a fractured hydrogel
US5234841A (en) * 1987-12-18 1993-08-10 Eastman Kodak Company Methods of preparing a polymeric latex composition and water-insoluble biological reagent
US5013669A (en) * 1988-06-01 1991-05-07 Smithkline Diagnostics, Inc. Mass producible biologically active solid phase devices
FR2635019B1 (fr) * 1988-08-02 1992-06-12 Centre Nat Rech Scient Materiau capable de fixer les substances biologiques, et ses applications notamment comme support de chromatographie d'affinite
SE8900130L (sv) * 1989-01-16 1990-07-17 Klaus Mosbach Konceptet att med hjaelp av molekylavtrycksmetoden framstaella konstgjorda antikroppar genom imprinting av t ex antigener samt att framstaella konstgjorda entzymer genom imprintning med transition state analoger
WO1990010227A1 (en) 1989-02-27 1990-09-07 Biostar Medical Products, Inc. Method and diagnostic test kit for detection of anti-cardiolipin
US5428008A (en) * 1989-04-14 1995-06-27 Prp, Inc. Therapeutic composition of micellar structures capable of promoting hemotasis
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
EP0450099B1 (en) * 1989-10-19 1996-09-11 Yamasa Shoyu Kabushiki Kaisha Carrier for binding antiphospholipid antibody, immunoassay using the same, and kit therefor
US5580770A (en) * 1989-11-02 1996-12-03 Alliedsignal Inc. Support containing particulate adsorbent and microorganisms for removal of pollutants
WO1991010138A1 (en) 1989-12-27 1991-07-11 Baxter Diagnostics Inc. Method to immobilize cardiolipin, phosphatidyl choline and cholesterol to solid phase and immunoassay
IL93134A (en) * 1990-01-23 1997-11-20 Yissum Res Dev Co Doped sol-gel glasses for obtaining chemical interactions
CA2058769C (en) * 1990-04-06 1999-03-02 Steven Anthony Krilis Methods for determining phospholipids and antibodies thereof
DE4027728A1 (de) * 1990-08-31 1992-03-05 Bayer Ag Immobilisierung von organischen makromolekuelen oder biopolymeren in einer polymermembran
CA2109622A1 (en) * 1991-05-17 1992-11-26 Richard C. Fuisz New thermoplastic polymeric material and process for making same
WO1993001494A1 (en) * 1991-07-12 1993-01-21 Toxi Lab, Inc. Method and apparatus for improved solid phase extraction
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5424219A (en) * 1991-10-25 1995-06-13 Cytech Biomedical, Inc. Method of performing assays for biomolecules and solid supports for use in such methods
SE9103234D0 (sv) * 1991-11-04 1991-11-04 Bjoern Ekberg Foerfarande foer separering av enantiomerer av aryloxipropanolaminderivat och kiralt fastfaskromatografimaterial foer anvaendning vid foerfarandet
US5413924A (en) * 1992-02-13 1995-05-09 Kosak; Kenneth M. Preparation of wax beads containing a reagent for release by heating
US5372719A (en) * 1992-03-30 1994-12-13 Perseptive Biosystems, Inc. Molecular imaging
US5414075A (en) 1992-11-06 1995-05-09 Bsi Corporation Restrained multifunctional reagent for surface modification
US6022748A (en) * 1997-08-29 2000-02-08 Sandia Corporation - New Mexico Regents Of The University Of California Sol-gel matrices for direct colorimetric detection of analytes
WO1994017106A1 (en) * 1993-01-19 1994-08-04 Pharmacia P-L Biochemicals, Inc. Storage and delivery of purified protein reagents with carrier wax
US5599660A (en) * 1993-01-19 1997-02-04 Pharmacia Biotech Inc. Method and preparation for sequential delivery of wax-embedded, inactivated biological and chemical reagents
ES2176588T3 (es) * 1993-02-03 2002-12-01 Histaggen Inc Procedimiento para almacenar un ligando dentro de un medio contencion liberable y procedimiento para liberar un ligando del mismo.
US5472852A (en) * 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients
US5994110A (en) * 1995-02-10 1999-11-30 Mosbach; Klaus Methods for direct synthesis of compounds having complementary structure to a desired molecular entity and use thereof
US6127154A (en) * 1994-02-10 2000-10-03 Mosbach; Klaus Methods for direct synthesis of compounds having complementary structure to a desired molecular entity and use thereof
US5739244A (en) * 1994-03-23 1998-04-14 Fisk; Donald Polymer composition containing prime starch
US5582907A (en) * 1994-07-28 1996-12-10 Pall Corporation Melt-blown fibrous web
AT401653B (de) * 1994-10-05 1996-11-25 Avl Verbrennungskraft Messtech Verfahren zur immobilisierung biologischer komponenten in einer polymermatrix sowie biosensoren unter verwendung derartiger immobilisate
WO1996037527A1 (en) * 1995-05-26 1996-11-28 Igen, Inc. Molecularly imprinted beaded polymers and stabilized suspension polymerization of the same in perfluorocarbon liquids
US6027721A (en) * 1996-05-20 2000-02-22 Cytotherapeutics, Inc. Device and method for encapsulated gene therapy
US6054142A (en) * 1996-08-01 2000-04-25 Cyto Therapeutics, Inc. Biocompatible devices with foam scaffolds
US6177282B1 (en) * 1997-08-12 2001-01-23 Mcintyre John A. Antigens embedded in thermoplastic
US7018798B2 (en) * 1997-08-12 2006-03-28 Embedded Concepts, Llc Nucleic acid antigens embedded in thermoplastic

Also Published As

Publication number Publication date
EP1715342A1 (en) 2006-10-25
US6177282B1 (en) 2001-01-23
AU753093B2 (en) 2002-10-10
DE69835154T2 (de) 2007-06-06
EP1005652A4 (en) 2002-06-26
WO1999008113A1 (en) 1999-02-18
CA2300381A1 (en) 1999-02-18
EP1005652B1 (en) 2006-07-05
EP1005652A1 (en) 2000-06-07
JP2001512832A (ja) 2001-08-28
AU8902298A (en) 1999-03-01
US6872576B1 (en) 2005-03-29
ES2268786T3 (es) 2007-03-16
DE69835154D1 (de) 2006-08-17
US20050042774A1 (en) 2005-02-24

Similar Documents

Publication Publication Date Title
DK1005652T3 (da) Bindingsassay under anvendelse af antigener indlejret i termoplast
DE69808854D1 (de) Buchbindevorrichtung
ATA898A (de) Snowboard - einstiegsbindung
LTC0975754I2 (lt) Osteoprotegeriną rišantys baltymai ir receptoriai
DK1003781T3 (da) Interleukin-18-bindende proteiner, fremstilling og anvendelse af disse
FI963560A7 (fi) Sidontamääritys, jossa käytetään häntäryhmiä sisältäviä sidonta-aineita
ATE345142T1 (de) Substantiell reine histidin-gebundene protein polymerkonjugate
EE200000148A (et) Kay - uus immuunsüsteemi valk
DE69935516D1 (de) Antikörper mit verbesserter produzierbarkeit
DE69720284D1 (de) Geformtes klebmittel
ATE241947T1 (de) Absorbierende artikel mit verbesserter passform bei nässe
NO972863L (no) Skibinding
DE69830061D1 (de) Emulgiertes bituminöses bindemittel
DE69727549D1 (de) Matte
DE69812897D1 (de) Lumineszierdes spezifisches bindungsassay
FI971338A0 (fi) Muovipohjainen materiaali
DE69833267D1 (de) Thermoplastische harzzusammensetzung
NO996354L (no) Perifert virkende antikløe-opiater
ID20854A (id) Bahan tambahan deterjen antimikroba
DE69825330D1 (de) Ski mit Bindungsvorrichtung
DE19842713B8 (de) Thermoplastische Harzzusammensetzung
DE59801028D1 (de) Kunststoffelement
DE59812059D1 (de) Drosselelement
DE69803627D1 (de) Immunoassay-Element
DK0991353T3 (da) Klemindretning